Oracle Alpha’s Accendra Health ACH Stock Holding History

Oracle Alpha’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$391K	Sell	14,094 -2,227	-14%	-$49.5K	0.7%	36
2023 Q4	$315K	Buy	+16,321	New	+$296K	0.41%	95

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oracle Alpha's ACH Position: Q1 2024 in Review

Oracle Alpha reduced its Accendra Health (ACH) stake by 14% in Q1 2024, selling an estimated $49.5K and leaving 14,094 shares worth $391K. The position accounts for 0.7% of the portfolio, ranked #36.

Oracle Alpha first reported a position in ACH in Q4 2023 and has held it in 2 quarters since. 231 funds tracked by Wall St. Rank hold ACH as of Q1 2024.

Oracle Alpha held 14,094 shares of Accendra Health worth $391K as of Q1 2024.
Oracle Alpha sold 2,227 Accendra Health shares in Q1 2024, an estimated $49.5K.
Accendra Health made up 0.7% of Oracle Alpha's portfolio in Q1 2024, its #36 holding.
Oracle Alpha first reported a position in Accendra Health in Q4 2023 and has held it in 2 quarters since.
231 funds tracked by Wall St. Rank held Accendra Health as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.